Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

News Go to news feed

Agfa-Gevaert: growth in Q2 2026, but weak free cash flow weighs

Agfa-Gevaert reported a currency-adjusted revenue increase of 2.6% in the second quarter and an improved adjusted EBITDA, while free cash flow remained negative at -€10m in Q2 (first half: -€52m). Order intake in HealthCare IT rose 28%, cloud orders more than tripled and accounted for 50% of the volume, with many orders from new customers. Net debt increased to €74m and available credit facilities are largely drawn, but management highlights a transformation program with annualized savings of €61m. The company expects continued growth in Digital Printing Solutions, a recovery for ZIRFON only in 2027, and a positive full-year result according to analyst estimates. » More on de.investing.com
Agfa-Gevaert reduces first-quarter loss thanks to cost cuts and passing on higher silver prices

Agfa-Gevaert reported a net loss of €12m for the first quarter versus €20m a year earlier and revenue of €236m, currency-adjusted +1.7%, but below the consensus estimate of €241m. Adjusted EBITDA rose to €12m, adjusted EBIT to €3m and gross profit was €76m. The company attributes improved profitability to savings programs, strict cost control and passing higher silver prices on to customers. The Digital Printing Solutions division grew, while Green Hydrogen Solutions suffered from market weakness. For 2026 Agfa-Gevaert expects increases in revenue and profitability versus 2025, but anticipates a more negative free cash flow because of transformation and the silver business. » More on de.investing.com
Agfa-Gevaert Q3 2025: revenue falls 7.1% — adjusted EBITDA plunges

Agfa-Gevaert reports a Q3 2025 revenue decline of 7.1% to €257 million and an adjusted EBITDA that collapsed 65.9% to €5 million; the share price then fell about 7.7% to €0.77. Positive free cash flow of €21 million was supported by working-capital improvements and one-off effects, while net debt edged up to €492 million. The company is accelerating restructurings, expanding the cost-cutting program by €25 million and pushing the transition of HealthCare IT to a cloud-SaaS model. For the near term, Agfa-Gevaert still expects challenges in mature segments like Radiology Solutions but sees growth potential in Digital Print & Chemicals and Green Hydrogen Solutions. » More on de.investing.com
Agfa Gevaert reports decline in adjusted EBITDA and strong healthcare IT outlook

Agfa Gevaert released mixed Q2 2025 results: adjusted EBITDA fell by €9 million, gross profit in radiology decreased by €13 million, while free cash flow improved by €45 million. The stock dropped about 4.9% after the numbers; the Healthcare IT segment, however, shows strong growth potential with expected mid- to high-double-digit growth rates. CEO Pascal Duery highlighted the positive trend in Healthcare IT and the shift from project revenue to subscription models. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2010, Agfa-Gevaert has already paid €0.32 in dividends. The last payout was in November 2010.

Financials

In the last quarter, Agfa-Gevaert had revenue of €205.54M and net profit of -€23.49M

(EUR)	September 2026	YoY
Revenue	205.54M	20.02%
Gross profit	46.98M	31.91%
Net profit	-23.49M	23.64%
EBITDA	-6.85M	37.03%

Fundamentals

Metric	Value
Market capitalization	€80.15M
Number of shares	154.82M
52-week high/low	€1.05 - €0.52
Dividends	No
Beta	0.61
P/E ratio	-0.49
PEG ratio	0.01
P/B ratio	0.26
P/S ratio	0.05

Company profile

Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems, and IT solutions worldwide. The company's Offset Solutions segment provides commercial, newspaper, and packaging printers; integrated prepress and printing solutions, including computer-to-plate systems using digital offset printing plates, pressroom supplies, and software for workflow optimization, color management, screening, and print standardization; and security printing software solutions. Its Radiology Solutions segment offers analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. The company's Healthcare IT segment provides picture archiving and communication systems; hospital information system and clinical information systems; and integrated care solutions. Its Digital Print & Chemicals segment offers inkjet printers for sign and display printing companies; inkjet inks and fluids for industrial inkjet applications, such as signs, posters and displays, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; membranes to the hydrogen production industry, as well as for printable synthetic papers; UV-curable and water based inks for various industrial applications. This segment also provides films for micrography, non-destructive testing, aerial photography and printed circuit board production; specialty foils for security documents and print media; and conductive polymers and materials for the production of high-security ID documents. The company sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.